CN100537567C - 作为抗菌剂中间体的芳基取代的噁唑烷酮的制备方法 - Google Patents

作为抗菌剂中间体的芳基取代的噁唑烷酮的制备方法 Download PDF

Info

Publication number
CN100537567C
CN100537567C CNB2005800249846A CN200580024984A CN100537567C CN 100537567 C CN100537567 C CN 100537567C CN B2005800249846 A CNB2005800249846 A CN B2005800249846A CN 200580024984 A CN200580024984 A CN 200580024984A CN 100537567 C CN100537567 C CN 100537567C
Authority
CN
China
Prior art keywords
compound
formula
methyl
vii
viii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005800249846A
Other languages
English (en)
Chinese (zh)
Other versions
CN1989133A (zh
Inventor
J·彻里曼
M·W·库思伯特
J·杜比茨
G·E·霍维尔斯
K·R·穆尔霍兰德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1989133A publication Critical patent/CN1989133A/zh
Application granted granted Critical
Publication of CN100537567C publication Critical patent/CN100537567C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNB2005800249846A 2004-05-25 2005-05-24 作为抗菌剂中间体的芳基取代的噁唑烷酮的制备方法 Expired - Fee Related CN100537567C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0411596.0A GB0411596D0 (en) 2004-05-25 2004-05-25 Chemical process
GB0411596.0 2004-05-25

Publications (2)

Publication Number Publication Date
CN1989133A CN1989133A (zh) 2007-06-27
CN100537567C true CN100537567C (zh) 2009-09-09

Family

ID=32670975

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005800249846A Expired - Fee Related CN100537567C (zh) 2004-05-25 2005-05-24 作为抗菌剂中间体的芳基取代的噁唑烷酮的制备方法

Country Status (6)

Country Link
US (1) US20090105484A1 (enExample)
EP (1) EP1753751A1 (enExample)
JP (1) JP2008500316A (enExample)
CN (1) CN100537567C (enExample)
GB (1) GB0411596D0 (enExample)
WO (1) WO2005116017A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US8604209B2 (en) 2008-10-10 2013-12-10 Trius Therapeutics, Inc. Methods for preparing oxazolidinones and compositions containing them
BRPI1008829A2 (pt) 2009-02-03 2016-03-15 Trius Therapeutics forma cristalina de dihidrogenofosfato de (r)-3-(4-(2-(2-metiltetrazol-5-il) piridin-5-il)-3-fluorofenil)-5-hidroximetil oxazolidin-2-ona
US8580767B2 (en) 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1639136A (zh) * 2001-09-11 2005-07-13 阿斯特拉曾尼卡有限公司 作为抗菌剂的噁唑烷酮和/或异噁唑啉

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1248760B8 (en) * 2001-01-22 2007-11-14 Council of Scientific and Industrial Research An eco-friendly method of preparation of high purity tetrabromobisphenol-a
DE60210654T2 (de) * 2001-10-25 2007-01-25 Astrazeneca Ab Aryl substituierte oxazolidinone mit antibacterieller activität
JP2005524661A (ja) * 2002-02-28 2005-08-18 アストラゼネカ アクチボラグ ３−シクリル−５−（窒素含有５員環）メチル−オキサゾリジノン誘導体と抗菌剤としてのその使用
JP2003335762A (ja) * 2002-05-20 2003-11-28 Meiji Seika Kaisha Ltd 新規ビフェニル誘導体
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1639136A (zh) * 2001-09-11 2005-07-13 阿斯特拉曾尼卡有限公司 作为抗菌剂的噁唑烷酮和/或异噁唑啉

Also Published As

Publication number Publication date
WO2005116017A1 (en) 2005-12-08
EP1753751A1 (en) 2007-02-21
US20090105484A1 (en) 2009-04-23
JP2008500316A (ja) 2008-01-10
GB0411596D0 (en) 2004-06-30
CN1989133A (zh) 2007-06-27

Similar Documents

Publication Publication Date Title
US8754230B2 (en) 4-pyridinone compounds and their use for cancer
EP1137634A1 (en) Process for the synthesis of azetidinones
CN113666909B (zh) 一种托匹司他的制备方法
CN112174880A (zh) 一种1,3,4,6-四取代吡啶酮衍生物的制备方法
CN100537567C (zh) 作为抗菌剂中间体的芳基取代的噁唑烷酮的制备方法
US9663490B2 (en) Process for making reverse transcriptase inhibitors
CN114450270B (zh) 砜吡草唑的制备方法和中间体
JP3156026B2 (ja) ホスホン酸ジエステル誘導体
JP2024516289A (ja) Ｔｒｅｘ１のモジュレーター
HU195780B (en) Process for production of derivatives of substituated dihydroquinolone carbonic acid
JP5656838B2 (ja) 置換イソキノリンを合成するための方法
KR20000070523A (ko) 피라졸 유도체
Lee et al. Regioselective alkylation and arylation at the 6-position of pyrimidine: Synthesis of 5-alkyl-6-arylmethyl-2, 4-pyrimidinediones
KR102743629B1 (ko) 선택적 에스트로겐 수용체 분해제의 제조 방법
JP2006513271A (ja) ホスホジエステラーゼ−４阻害剤の製造方法
Uenishi et al. COUPLING OF CONSECUTIVE PYFUDINE RING UNITS FOR OLIGOPYRIDINE SYNTHESIS
JP5206931B2 (ja) ジオキサジニルピラゾール化合物の製造方法および中間体
Shetty et al. Palladium catalyzed α-arylation of methyl isobutyrate and isobutyronitrile: an efficient synthesis of 2, 5-disubstituted benzyl alcohol and amine intermediates
JPH0316352B2 (enExample)
JPH1072450A (ja) ピリミジノン化合物の製造方法
JP2023503573A (ja) ２－チオアルキルピリミジンの合成のための方法
CA2616075A1 (en) Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
Molnár Selected reactions of 4h-pyrido [1, 2-a] pyrimidin-4-ones and an azoxyquinoxaline
JPWO1997030965A1 (ja) α−アルコキシフェニル酢酸誘導体の製造法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090909

Termination date: 20100524